Gam Holding Ag Incyte Corp Transaction History

Gam Holding Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$73.04 - $95.72 $995,096 - $1.3 Million	-13,624 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$72.82 - $86.52 $183,797 - $218,376	2,524 Added 22.74%	13,624 $1.01 Million
Q1 2019 May 10, 2019	SELL	$63.56 - $88.17 $763,482 - $1.06 Million	-12,012 Reduced 51.97%	11,100 $955,000
Q3 2018 Nov 13, 2018	BUY	$61.75 - $74.23 $123 - $148	2 Added 0.01%	23,112 $1.6 Million
Q2 2018 Aug 09, 2018	SELL	$60.85 - $83.98 $808,696 - $1.12 Million	-13,290 Reduced 36.51%	23,110 $1.55 Million
Q3 2017 Nov 14, 2017	SELL	$109.15 - $138.27 $3.22 Million - $4.08 Million	-29,532 Reduced 44.79%	36,400 $4.25 Million
Q2 2017 Aug 07, 2017	BUY	N/A	65,932	65,932 $8.3 Million

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.